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Dragstedt believed that basal hypersecretion of gastric acid was the root cause
of duodenal ulcer, that the hypersecretion was due to an increased vagal stimu-
lation, and that vagotomy would therefore cure duodenal ulcer. He introduced
vagotomy and demonstrated that the operation was successful in curing most
patients of their duodenal ulcers. This article reviews how further research in
the succeeding half century has demonstrated that it is the effect of vagotomy
on stimulated, rather than upon basal secretion that cures duodenal ulcer and
that the apparent basal hypersecretion of patients with duodenal ulcer is due to
an increased parietal cell mass. The article points out that there is no convinc-
ing explanation as yet ofthe mechanism whereby vagotomy reduces histamine-
stimulated gastric secretion.
INTRODUCTION
Dragstedt's massive contribution as scientist and surgeon was to introduce vagal sec-
tion as a treatment for chronic duodenal ulcer. His rationale was pithily summarized by
him in 1956 [1]: "I believe that duodenal ulcers are due to a hypersecretion ofgastricjuice
in the empty stomach dependent upon excessive and abnormal secretory impulses in the
vagus nerves." He emphasized in his first [2] and subsequent publications [3-5] that noc-
turnal (i.e., basal) secretion was greatly reduced by operation, usually to a level less than
that seen in normal controls.
The purpose of this review, 50 years after his seminal paper, is to examine
Dragstedt's hypothesis in the light ofsubsequent advances in knowledge. The links in the
chain that require examination are:
1. Is duodenal ulcer associated with increased gastric acid secretion?
2. Does vagotomy reduce gastric acid secretion? And is any such reduction related
to freedom from recurrence ofthe disease?
3. Ifthe above are confirmed, is restingjuice the element ofgastric secretion that it
is critical to reduce, or is it some other aspect that is fundamental?
4. How does vagotomy reduce gastric secretion?
IS DUODENAL ULCER ASSOCIATED WITH INCREASED
GASTRIC ACID SECRETION?
There is no reasonable doubt that this association exists in terms of maximally (his-
tamine or pentagastrin) stimulated secretion [6]. Maximal gastric secretion, i.e., the output
rate ofacid that can be achieved using maximal concentrations ofa powerful secretagogue
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such as histamine or pentagastrin, is an important concept in gastric physiology because
there is evidence that it represents the stimulated output of the whole of the parietal cell
population [7, 8], the parietal cell mass as it is usually called. However, there is consider-
able overlap between the ranges of maximal gastric secretion of normal subjects and
duodenal ulcer patients [9] so that the maximal secretion of about three-quarters of duo-
denal ulcer subjects lies within the range of normal and only one-quarter ofnormals have
a gastric secretion so low as to lie below the lower boundary ofthe duodenal ulcer group.
Maximal gastric secretion depends on lean body mass [10] and other attributes of stature
together with age [11], but these factors are not sufficient to explain the overlap.
Nevertheless, the measurement of maximal secretion in any individual enables one to
assess the chance that he comes from the duodenal ulcer rather than the control group,
and that chance increases regularly with increasing secretion [12].
Have we a candidate to postulate as a likely cause for the increased maximal secre-
tion? The answer is yes, but it is necessary to diverge from the main argument to consid-
er the history of the relationship between cigarette smoking and duodenal ulcer.
Cigarette smoking andprevalence ofduodenal ulcer
In 1927, Barnett was the first person to notice that duodenal ulcer seemed to be
more common in habitual smokers than in non-smokers, although he did not believe that
the association was meaningful [13]. Later observers were more impressed by the rela-
tionship, and in 1979 Harrison [14] reviewed six major studies and found that the mean
prevalence ratio of duodenal ulcer in smokers compared with nonsmokers was 1.9:1. A
subsequent epidemiological survey showed that in men, 75 percent of the attributable
risk of duodenal ulcer could be abolished by removing (statistically) exposure to smok-
ing and alcohol, alone or in combination [15]. This is of an order similar to that
observed between cigarette smoking and lung cancer. More recently, an endoscopic sur-
vey of 1200 outpatients found a prevalence ratio of 7.8:1 [16].
Smoking and treatment ofduodenal ulcer
There is also evidence that smoking has a deleterious effect on the healing rate of
duodenal ulcer in response to H2 antagonists and on the duration of the symptom-free
period after the healing of a duodenal ulcer [17].
Smoking andgastric acid secretion
Does the effect of smoking on the incidence, rate ofhealing and relapse rate ofduo-
denal ulcer act through an increase of parietal cell mass? The published evidence is sub-
stantially in favor of an association between cigarette smoking and maximal gastric
secretion [18-22].
The last two quoted papers demonstrated that in patients with duodenal ulcer who
smoke, there is a highly significant direct correlation between maximal gastric secretion
and the total number of cigarettes that the individual has smoked. Standardization of
maximal gastric secretion to zero smoking, i.e., mathematically expunging the putative
effect of smoking on maximal gastric secretion, reduces the maximal secretion of these
duodenal ulcer smokers towards, if not completely to, the range ofnormal non-smokers.
If this positive relationship between smoking and maximal gastric secretion is
causative, we do not know the precise mechanism, but there is some suggestion that
chronic smoking acts through the effect of acute smoking [23]. When the subject
smokes a cigarette, after a plateau of sub-maximally stimulated gastric secretion has
been reached during a continuous intravenous infusion of histamine, the gastric secre-
tion is reduced below the plateau value. The repetition ofthis phenomenon several times
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each day must lower the average acidity of the gastric contents, and we know that a ten-
dency towards alkalinity in the neighborhood of the pyloric antrum increases the gastrin
drive. Gastrin is not only a secretagogue: it also stimulates hyperplasia of parietal cells.
And it is the total number ofparietal cells, the parietal cell mass, that determines maximal
gastric secretion. Whatever the mechanism, the evidence is solid that the risk ofdevelop-
ing a duodenal ulcer is positively related to the number of parietal cells present in the
subject's stomach; and also to smoking, as discussed above.
The advent ofHelicobacterpylori has not destroyed the relationship between duode-
nal ulcer, maximal gastric secretion and smoking. The precise role ofthe organism in the
etiology ofduodenal ulcer remains undecided. In some series, over 90 percent of patients
with duodenal ulcer have the organism in their gastric mucus, and there are many reports
that eradicating the organism with antibiotics, especially in combination with protein
pump inhibitors, provides longer periods of healing even amounting to "cure." On the
other hand, in some countries the organism is highly prevalent despite the fact that duode-
nal ulcers are rare. Clearly, much further work needs to be done, but from the viewpoint
of this review the important consideration is that H. pylori, if it produces duodenal ulcer,
does not do so by increasing maximal gastric secretion. The latest evidence seems quite
clear that it reduces maximal gastric secretion [24].
DOES VAGOTOMY REDUCE GASTRIC ACID SECRETION?
Most authors who have studied basal secretion before and after vagotomy agreed that
the operation reduces basal secretion, by anything between 50-90 percent [25-27], but the
small volumes of gastric juice obtained from the unstimulated stomach and the apparent
variability of basal secretion between 10- or 15-min collection periods resulted in a con-
siderable overlap between the pre- and post-operative groups [28-30]. It was therefore
difficult to deduce from changes in basal secretion whether an adequate vagotomy has
been performed. Indeed, it now seems likely that the observations of these authorities
were in error because they did not take into account the collection errors that beset aspi-
rated gastric juice samples, especially when the secretion rate is low. After all possible
collection errors (pyloric loss, sequestration within the stomach, duodenogastric reflux)
[31-33] are corrected, one cannot demonstrate a reduction in basal secretion after vagoto-
my [34], although that study confirmed that patients with duodenal ulcer as a group had a
significantly greater basal secretion than normal subjects. On the basis of this evidence
one must conclude that the case for basal hypersecretion being the cause for duodenal
ulcer, and elimination of this basal hypersecretion by vagotomy being the explanation of
the efficacy ofthe operation at healing duodenal ulcer is not proven.
Theoretically, the correct test for the effect ofthe presence or absence ofvagal inner-
vation on gastric secretion should be something like the insulin-hypoglycemia test of
Hollander [35]: in the presence of the vagus, hypoglycemia stimulates the vagal center to
drive secretion. A huge literature grew up about the post-vagotomy insulin test, in partic-
ular attempting to define its use to indicate a "complete" vagotomy. The Hollander crite-
ria [36, 37] were the first and the most popular but were unreliable because they depend-
ed upon the titratable acidity of the gastric juice, that is the variable whose measurement
is the most likely to be inaccurate because of alkaline duodenogastric reflux [38]. If
secretion in response to insulin were corrected for reflux, and also for pyloric losses and
sequestration (the index known as VGb) and standardized for stature, the level to which it
fell after vagotomy provided a better prognostic index for the risk of recurrence [39].
The hypoglycemia produced by insulin is unpleasant and could be dangerous, and
vagal stimulation by sham feeding produced a smaller response with the vagus intact than
did insulin and therefore provided a less sensitive index. Histamine-stimulated secretion
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is also reduced by vagotomy [14 and numerous other papers], and again it was found that
the level to which histamine-stimulated secretion fell after vagotomy provided an accu-
rate prognostic index ofthe likelihood of a long-lasting cure [40].
WHAT ELEMENT OF GASTRIC SECRETION IS IT CRITICAL TO REDUCE?
Some comments above have indicated that the essence of the prognosis about
whether the duodenal ulcer is likely to have been cured by the vagotomy is given by the
level to which histamine- or insulin-stimulated secretion falls. Furthermore, it cannot be
convincingly demonstrated that vagotomy reduces basal secretion [34] The same paper,
however, confirmed that basal secretion is indeed larger in duodenal ulcer patients than in
normal controls.
These three statements do not fit very comfortably together. Dragstedt interpreted the
increased basal secretion in duodenal ulcer patients compared with controls (the
"increased vagal drive") as the cause of the duodenal ulcer disease. He knew that vagoto-
my would reduce stimulated gastric secretion and therefore reasoned that the operation
should reduce basal gastric secretion and thereby cure the ulcer. This reasoning seemed to
be supported by the excellent clinical results of vagotomy: the ulcers healed, and in most
cases remained healed. While in the early days, the evidence suggested that the vagotomy
reduced basal secretion, that seemed further support for his hypothesis. However, it now
appears that basal secretion is not reduced by vagotomy, so it is difficult to accept that the
increased vagal drive caused the ulcer. And yet the vagotomy does heal the ulcer and is
associated with a reduction in stimulated gastric secretion. What is the cause of the basal
hypersecretion if it does not respond to vagotomy, and why is it present in patients with
duodenal ulcer ifit is not the cause ofthe ulcer?
A recent study [41] has answered these questions. Dose-response curves were con-
structed for increasing doses (including zero, i.e., basal secretion) of histamine in patients
with duodenal ulcer and control subjects, including both smokers and non-smokers.
These curves were analyzed mathematically by the Hofstee transformation, which con-
verts the parabola of the dose-response curve into a straight line rather than the more
familiar Lineweaver-Burke plot because the Hofstee has been found to be more reliable
in the circumstances of this study [42 and Figure 1]. The parameters obtained by this
technique are VGmax, the theoretical maximal secretion that would be obtained with an
infinite dose of histamine, and Kx, the dose producing half the theoretical maximal
response. Not surprisingly, duodenal ulcer patients had a greater maximal secretion than
controls, but the half-response doses were identical. Moreover, basal secretion as a frac-
tion of the theoretical maximum was identical in the two groups. Smokers did not differ
from non-smokers in respect ofthese parameters.
We may now try to put together all the findings of this sensitivity study. The
increased basal secretion of patients with duodenal ulcer turns out to be a scale-
phenomenon: the larger parietal cell mass, as measured with maximal histamine, pro-
duces a larger acid output response to whatever is the stimulus that evokes resting gastric
secretion. The two other possible explanations that were available before this study have
been explicitly ruled out by the study. There is no increased sensitivity of the parietal
cells to a normal, basal drive because the fraction (basal secretion/maximal secretion) in
duodenal ulcer patients is identical with that in normal controls. Similarly, there is no
increased basal drive acting upon cells of normal sensitivity. The conclusion has to be
that the greater resting secretion in patients with duodenal ulcer is due to a normal basal
drive acting upon a larger number ofnormally-sensitive parietal cells. Smoking alters nei-
ther basal drive nor parietal cell sensitivity but, as discussed previously, increases maxi-
mal gastric secretion by increasing the number ofparietal cells
176Hobsley: Dragstedt, acidandduodenal ulcer
HOW DOES VAGOTOMY REDUCE GASTRIC SECRETION?
We now know so much about the receptors, messengers and the hydrogen ion pump
of the parietal cell and its relations with the ECL cell, that this question may seem super-
fluous. Yet in many ways this abundance ofknowledge is illusory. We know that vagoto-
my reduces maximal gastric secretion as evoked by a "maximal" dose of histamine, but
we do not know how this effect is achieved. The problem is that there are two viewpoints
ofthe relationship between vagally stimulated and maximally (histamine) stimulated gas-
tric secretion that remain difficult to reconcile. One claims that the vagus in some way
heightens the sensitivity ofthe parietal cell to histamine so that, provided the vagal inner-
vation of the stomach is intact, the histamine produces maximal secretion. According to
this view, vagotomy results in a submaximal response of the parietal cells to histamine
because ofthe lack ofthis background ofsensitization. On the other hand, many secretion
data point to the firing ofaparietal cell being an all-or-none response [7, 8].
The facts of the relationship between insulin- and histamine-stimulated secretion in
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Figure 1. Hypothetical dose response curves for the output-rate of gastric acid secretion in
response to an agonist. Both dose and response are in arbitrary units. The curve marked "secre-
tion" represents a normal subject, that marked sens+, a subject with increased sensitivity, and that
marked PCM+, a subject with an increased parietal cell mass. All three curves rise to a plateau at
maximal dose, but the plateau reached by the PCM+ curve is higher than that of the other two
curves because it represents the output of a larger number of fully-stimulated parietal cells. At a
dose of two units, which one may represent as basal secretion, the secretion of both the abnormal
subjects is equal, and greater than that ofthe normal subject. However, the fraction (basal/maximal)
is greater for the sens+ curve than for the PCM+ curve, the latter fraction having the same value as
on the normal curve. The same basal secretion on the normal curve might have represented an
increased basal drive, but in that case the fraction (basal/maximal) secretion would also have been
greater than normal.The evidence suggests that duodenal ulcer subjects owe theirapparently greater
basal secretion neither to increased basal drive nor to increased parietal cell sensitivity, but to an
increased parietal cell mass.
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exceeds vagally stimulated secretion by a constant amount per unit time, and that there is
no significant difference in this excess whether the vagus is normal or the patient has had
a complete vagotomy or an incomplete vagotomy [40]. This constant excess militates
against a sensitization phenomenon, which might be expected to follow a dose-related
pattern in which case the excess after a partial vagotomy would be less than after com-
plete vagotomy. Instead it favors the suggestion made in that paper that there are two
types ofparietal cells: one responds to either histamine or the vagus, but only ifthe vagal
innervation ofthe cell is intact; the other responds only to histamine but not to the vagus,
and the histamine-response does not require the vagal innervation to be intact. As far as
the writer knows, this suggestion has not been further explored. In the light of present
knowledge, the link might be provided by the ECL cell which we know to be the source
of histamine secretion. Maybe parietal cells, which have an ECL cell close by, have no
need to depend upon the vagus while those without such a neighbor require the vagal
stimulation before they will respond to histamine secreted by distant ECL cells.
CONCLUSION
No scientist ever explains "truth" so completely that the subject yields no new infor-
mation to subsequent workers. We need not be surprised, therefore, that Dragstedt's
hypothesis of an increased vagal drive and the consequent basal hypersecretion of acid as
the cause ofduodenal ulcer has not been supported by later work. Nevertheless, his oper-
ation of vagotomy worked: it reduced stimulated gastric secretion and the ulcers healed.
To a considerable extent, they stayed healed although, as with all treatments, there
were sometimes unwanted side-effects. Until the advent ofthe H2-antagonists, vagotomy
remained the most effective and reliable treatment for the condition, and with fewest
side-effects. At the same time, the vagotomy effect on gastric secretion led to an intense
study ofgastric secretory physiology, which has yielded much new scientific information
and still continues to be a productive vein. We indeed salute the memory of a great scien-
tist and a great surgeon.
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